Finanical Statements
Ibnsina Pharma (ISPH.CA) Reports 6 Months Standalone Results
Published at 12 August 2026 at 10:04Ibnsina PharmaRelated stock:Ibnsina Pharma stockAll Ibnsina Pharma disclosures
Disclosure summary
Company Name : Ibnsina Pharma
ISIN Code : EGS512O1C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 30/06/2026
Net Profit : 486,625,910
F/S Standalone Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 378,000,287
Audit Status : Reviewed
Source : Ibnsina Pharma
The Financial Statements in Arabic (3,501 KB)
The Financial Statements in English (3,424 KB)
ISIN Code : EGS512O1C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 30/06/2026
Net Profit : 486,625,910
F/S Standalone Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 378,000,287
Audit Status : Reviewed
Source : Ibnsina Pharma
The Financial Statements in Arabic (3,501 KB)
The Financial Statements in English (3,424 KB)